125 related articles for article (PubMed ID: 37196484)
1. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
[TBL] [Abstract][Full Text] [Related]
2. CDCA2 promotes proliferation and migration of melanoma by upregulating CCAD1.
Jin WH; Zhou AT; Chen JJ; Cen Y
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6858-6863. PubMed ID: 32633378
[TBL] [Abstract][Full Text] [Related]
3. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
[TBL] [Abstract][Full Text] [Related]
5. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
6. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
[TBL] [Abstract][Full Text] [Related]
7. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract][Full Text] [Related]
8. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
Chang X; Zhang H; Lian S; Zhu W
Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
[TBL] [Abstract][Full Text] [Related]
9. AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.
Puig-Butille JA; Vinyals A; Ferreres JR; Aguilera P; Cabré E; Tell-Martí G; Marcoval J; Mateo F; Palomero L; Badenas C; Piulats JM; Malvehy J; Pujana MA; Puig S; Fabra À
J Invest Dermatol; 2017 Jun; 137(6):1297-1310. PubMed ID: 28188776
[TBL] [Abstract][Full Text] [Related]
10. USP21 contributes to the aggressiveness of laryngeal cancer cells by deubiquitinating and stabilizing AURKA.
Wang QD; Shi T; Xu Y; Liu Y; Zhang MJ
Kaohsiung J Med Sci; 2023 Apr; 39(4):354-363. PubMed ID: 36919585
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract][Full Text] [Related]
12. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T
EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051
[TBL] [Abstract][Full Text] [Related]
14. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
Li K; Fan T; Shi Z; Jiang H
Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
[TBL] [Abstract][Full Text] [Related]
15. CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling.
Li J; Chen Y; Wang X; Wang C
J BUON; 2021; 26(3):882-888. PubMed ID: 34268949
[TBL] [Abstract][Full Text] [Related]
16. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
Wang S; Sun L
Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
[TBL] [Abstract][Full Text] [Related]
17. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
18. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
Yan C; Su H; Song X; Cao H; Kong L; Cui W
Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of aurora kinase A promotes vascular smooth muscle cell proliferation and migration by activating the GSK-3β/β-catenin pathway in aortic-dissecting aneurysms.
Meng J; Liu HL; Ma D; Wang HY; Peng Y; Wang HL
Life Sci; 2020 Dec; 262():118491. PubMed ID: 33011219
[TBL] [Abstract][Full Text] [Related]
20. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]